Long-term outcomes following percutaneous microwave ablation for colorectal cancer liver metastases

References

• Meijerink MR, Puijk RS, van Tilborg A, et al. Radiofrequency and microwave ablation compared to systemic chemotherapy and to partial hepatectomy in the treatment of colorectal liver metastases: a systematic review and meta-analysis. Cardiovasc Intervent Radiol. 2018;41(8):788–1204.
   Web of Science ®Google Scholar
• Hoffmann R, Rempp H, Clasen S. [Microwave tumor ablation. New devices, new applications?]. Radiologe. 2012;52(1):22–28.
   PubMed Web of Science ®Google Scholar
• Tsai S, Pawlik TM. Outcomes of ablation versus resection for colorectal liver metastases: are we comparing apples with oranges? Ann Surg Oncol. 2009;16(9):2422–2428.
   PubMed Web of Science ®Google Scholar
• Ruers T, Van Coevorden F, Punt CJ, et al. Local treatment of unresectable colorectal liver metastases: results of a randomized phase II trial. J Natl Cancer Inst. 2017;109(9):djx015.
   PubMedGoogle Scholar
• Scholefield JH, Eng C, editors. Colorectal Cancer. Diagnosis and Clinical Management. 1st ed., John Wiley & Sons, Ltd; 2014.
   Google Scholar
• Audisio RA. Atlas of procedures in surgical oncology with critical, evidence-based commentary notes (With Dvd-Rom). Singapore: World Scientific Publishing Company; 2009.
   Google Scholar
• Benson AB, 3rd, Venook AP, Cederquist L, et al. Colon cancer, version 1.2017, NCCN clinical practice guidelines in Oncology. J Natl Compr Canc Netw. 2017;15(3):370–398.
   PubMed Web of Science ®Google Scholar
• Brown G. Colorectal cancer. Leiden: Cambridge University Press; 2007.
   Google Scholar
• Gillams A, Goldberg N, Ahmed M, et al. Thermal ablation of colorectal liver metastases: a position paper by an international panel of ablation experts, the interventional oncology sans frontières meeting 2013. Eur Radiol. 2015;25(12):3438–3454.
   PubMed Web of Science ®Google Scholar
• Glynne-Jones R, Wyrwicz L, Tiret E, et al. Rectal cancer: ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2017;28(suppl_4):iv22–iv40.
   PubMed Web of Science ®Google Scholar
• Jenkins JE. Colorectal cancer: risk, Diagnosis, and treatments. New York: Nova Science Publishers, 2011.
   Google Scholar
• Van Cutsem E, Cervantes A, Adam R, et al. ESMO consensus guidelines for the management of patients with metastatic colorectal cancer. Ann Oncol. 2016;27(8):1386–1422.
   PubMed Web of Science ®Google Scholar
• Vogl TJ, Mack M, Eichler K, et al. Interventional thermal ablation of malignant liver tumors and liver metastases: comparison of radiofrequency ablation (RFA), laser-induced thermotherapy (LITT) and microwave ablation (MWA). Hessisches Aerzteblatt. 2011;10:10.
   Google Scholar
• Abdelaziz A, Elbaz T, Shousha HI, et al. Efficacy and survival analysis of percutaneous radiofrequency versus microwave ablation for hepatocellular carcinoma: an Egyptian multidisciplinary clinic experience. Surg Endosc. 2014;28(12):3429–3434.
   PubMed Web of Science ®Google Scholar
• Ahmed M, Solbiati L, Brace CL, et al. Image-guided tumor ablation: standardization of terminology and reporting criteria-a 10-year update. Radiology. 2014;273(1):241–260.
   PubMed Web of Science ®Google Scholar
• Boyvat F. Local ablation for Hepatocellular Carcinoma. Exp Clin Transplant. 2014;12(Suppl 1):55–59.
   PubMed Web of Science ®Google Scholar
• Correa-Gallego C, Fong Y, Gonen M, et al. A retrospective comparison of microwave ablation vs. radiofrequency ablation for colorectal cancer hepatic metastases. Ann Surg Oncol. 2014;21(13):4278–4283.
   PubMed Web of Science ®Google Scholar
• Ding J, Jing X, Liu J, et al. Complications of thermal ablation of hepatic tumours: comparison of radiofrequency and microwave ablative techniques. Clin Radiol. 2013;68(6):608–615.
   PubMed Web of Science ®Google Scholar
• Ierardi AM, Floridi C, Fontana F, et al. Microwave ablation of liver metastases to overcome the limitations of radiofrequency ablation. Radiol Med. 2013;118(6):949–961.
   PubMed Web of Science ®Google Scholar
• Liu C-H, Arellano RS, Uppot RN, et al. Radiofrequency ablation of hepatic tumours: effect of post-ablation margin on local tumour progression. Eur Radiol. 2010;20(4):877–885.
   PubMed Web of Science ®Google Scholar
• Martin RCG, Scoggins CR, McMasters KM. Safety and efficacy of microwave ablation of hepatic tumors: a prospective review of a 5-year experience. Ann Surg Oncol. 2010;17(1):171–178.
   PubMed Web of Science ®Google Scholar
• Groeschl RT, Wong RK, Quebbeman EJ, et al. Recurrence after microwave ablation of liver malignancies: a single institution experience. HPB. 2013;15(5):365–371.
   PubMed Web of Science ®Google Scholar
• Sofocleous CT, Petre EN, Gonen M, et al. CT-guided radiofrequency ablation as a salvage treatment of colorectal cancer hepatic metastases developing after hepatectomy. J Vasc Interv Radiol. 2011;22(6):755–761.
   PubMed Web of Science ®Google Scholar
• Solbiati L, Ahmed M, Cova L, et al. Small liver colorectal metastases treated with percutaneous radiofrequency ablation: local response rate and long-term survival with up to 10-year follow-up. Radiology. 2012;265(3):958–968.
   PubMed Web of Science ®Google Scholar
• Jiang B, Luo H, Yan K, et al. Ten-year outcomes of percutaneous radiofrequency ablation for colorectal cancer liver metastases in perivascular vs. non-perivascular locations: a propensity-score matched study. Front Oncol. 2020;10:553556.
   PubMed Web of Science ®Google Scholar
• Wang Y, Zheng J, Chen H, et al. A prognostic nomogram for colorectal cancer liver metastases after percutaneous thermal ablation. Int J Hyperthermia. 2018;34(6):853–862.
   PubMed Web of Science ®Google Scholar
• Shady W, Petre EN, Gonen M, et al. Percutaneous radiofrequency ablation of colorectal cancer liver metastases: factors affecting outcomes–a 10-year experience at a single center. Radiology. 2016;278(2):601–611.
   PubMed Web of Science ®Google Scholar
• Peng S, Huang P, Yu H, et al. Prognostic value of carcinoembryonic antigen level in patients with colorectal cancer liver metastasis treated with percutaneous microwave ablation under ultrasound guidance. Medicine. 2018;97(10):e0044.
   PubMed Web of Science ®Google Scholar
• Joo JH, Park J-h, Kim JC, et al. Local control outcomes using stereotactic body radiation therapy for liver metastases from colorectal cancer. Int J Radiat Oncol Biol Phys. 2017;99(4):876–883.
   PubMed Web of Science ®Google Scholar
• Iannitti DA, Martin RC, Simon CJ, et al. Hepatic tumor ablation with clustered microwave antennae: the US Phase II trial. HPB. 2007;9(2):120–124.
   PubMedGoogle Scholar
• van Amerongen MJ, Jenniskens SFM, van den Boezem PB, et al. Radiofrequency ablation compared to surgical resection for curative treatment of patients with colorectal liver metastases – a meta-analysis. HPB. 2017;19(9):749–756.
   PubMed Web of Science ®Google Scholar
• Takahashi H, Kahramangil B, Kose E, et al. A comparison of microwave thermosphere versus radiofrequency thermal ablation in the treatment of colorectal liver metastases. HPB. 2018;20(12):1157–1162.
   PubMed Web of Science ®Google Scholar
• Bhardwaj N, Strickland AD, Ahmad F, et al. Microwave ablation for unresectable hepatic tumours: clinical results using a novel microwave probe and generator. Eur J Surg Oncol. 2010;36(3):264–268.
   PubMed Web of Science ®Google Scholar
• Lorentzen T, Skjoldbye B, Nolsoe C. Microwave ablation of liver metastases guided by contrast-enhanced ultrasound: experience with 125 metastases in 39 patients. Ultraschall Med. 2011;32(5):492–496.
   PubMed Web of Science ®Google Scholar
• Yamashita S, Odisio BC, Huang SY, et al. Embryonic origin of primary colon cancer predicts survival in patients undergoing ablation for colorectal liver metastases. Eur J Surg Oncol. 2017;43(6):1040–1049.
   PubMed Web of Science ®Google Scholar
• Zhou F, Yu X, Liang P, et al. Does primary tumor location impact the prognosis of colorectal liver metastases patients after microwave ablation? Lessons from 10 years‘ experience. Oncotarget. 2017;8(59):100791–100800.
   PubMedGoogle Scholar
• Kaye EA, Cornelis FH, Petre EN, et al. Volumetric 3D assessment of ablation zones after thermal ablation of colorectal liver metastases to improve prediction of local tumor progression. Eur Radiol. 2019;29(5):2698–2705.
   PubMed Web of Science ®Google Scholar
• Sotirchos VS, Petrovic LM, Gonen M, et al. Colorectal cancer liver metastases: biopsy of the ablation zone and margins can be used to predict oncologic outcome. Radiology. 2016;280(3):949–959.
   PubMed Web of Science ®Google Scholar
• Wang X, Sofocleous CT, Erinjeri JP, et al. Margin size is an independent predictor of local tumor progression after ablation of colon cancer liver metastases. Cardiovasc Intervent Radiol. 2013;36(1):166–175.
   PubMed Web of Science ®Google Scholar
• Shady W, Petre EN, Do KG, et al. Percutaneous microwave versus radiofrequency ablation of colorectal liver metastases: ablation with clear margins (A0) provides the best local tumor control. J Vasc Interv Radiol. 2018;29(2):268–275 e1.
   PubMed Web of Science ®Google Scholar
• Kurilova I, Bendet A, Petre EN, et al. Factors associated with local tumor control and complications after thermal ablation of colorectal cancer liver metastases: a 15-year retrospective cohort study. Clinical Colorectal Cancer. 2021;20(2):e82–e95.
   PubMed Web of Science ®Google Scholar
• Han K, Kim JH, Yang SG, et al. A single-center retrospective analysis of periprocedural variables affecting local tumor progression after radiofrequency ablation of colorectal cancer liver metastases. Radiology. 2021;298(1):212–218.
   PubMed Web of Science ®Google Scholar
• Shady W, Petre EN, Vakiani E, et al. Kras mutation is a marker of worse oncologic outcomes after percutaneous radiofrequency ablation of colorectal liver metastases. Oncotarget. 2017;8(39):66117–66127.
   PubMedGoogle Scholar
• Cornelis FH, Petre EN, Vakiani E, et al. Immediate postablation 18F-FDG injection and corresponding SUV are surrogate biomarkers of local tumor progression after thermal ablation of colorectal carcinoma liver metastases. J Nucl Med. 2018;59(9):1360–1365.
   PubMed Web of Science ®Google Scholar
• Calandri M, Yamashita S, Gazzera C, et al. Ablation of colorectal liver metastasis: interaction of ablation margins and RAS mutation profiling on local tumour progression-free survival. Eur Radiol. 2018;28(7):2727–2734.
   PubMed Web of Science ®Google Scholar
• Odisio BC, Yamashita S, Huang SY, et al. Local tumour progression after percutaneous ablation of colorectal liver metastases according to RAS mutation status. Br J Surg. 2017;104(6):760–768.
   PubMed Web of Science ®Google Scholar
• Sofocleous CT, Garg S, Petrovic LM, et al. Ki-67 is a prognostic biomarker of survival after radiofrequency ablation of liver malignancies. Ann Surg Oncol. 2012;19(13):4262–4269.
   PubMed Web of Science ®Google Scholar
• Sotirchos VS, Fujisawa S, Vakiani E, et al. Fluorescent tissue assessment of colorectal cancer liver metastases ablation zone: a potential real-time biomarker of complete tumor ablation. Ann Surg Oncol. 2019;26(6):1833–1840.
   PubMed Web of Science ®Google Scholar
• Tanis E, Spliethoff JW, Evers DJ, et al. Real-time in vivo assessment of radiofrequency ablation of human colorectal liver metastases using diffuse reflectance spectroscopy. Eur J Surg Oncol. 2016;42(2):251–259.
   PubMed Web of Science ®Google Scholar
• Beermann M, Lindeberg J, Engstrand J, et al. 1000 Consecutive ablation sessions in the era of computer assisted image guidance – lessons learned. Eur J Radiol Open. 2019;6:1–8.
   PubMed Web of Science ®Google Scholar